A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2. (Q43062314)
Jump to navigation
Jump to search
scientific article published on 14 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2. |
scientific article published on 14 May 2010 |
Statements
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2 (English)
Joseph Paul Eder
Geoffrey I Shapiro
Andrew X Zhu
Dale Miles
Harold Keer
Belinda Cancilla
Felix Chu
Suzanne Hitchcock-Bryan
Laurie Sherman
Elisabeth I Heath
Scott A Boerner
Patricia M LoRusso